Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 02, 2013 16:10 ET | Source: Acura Pharmaceuticals, Inc.

Acura Pharmaceuticals Announces First Quarter 2013 Financial Results

PALATINE, IL--(Marketwired - May 2, 2013) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company developing products intended to address medication abuse and misuse,...
April 22, 2013 16:15 ET | Source: Acura Pharmaceuticals, Inc.

Acura Pharmaceuticals to Host First Quarter 2013 Financial Results Conference Call on May 3, 2013

PALATINE, IL--(Marketwired - Apr 22, 2013) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs, today announced that the company...
April 04, 2013 16:15 ET | Source: Acura Pharmaceuticals, Inc.

Acura Pharmaceuticals Awarded U.S. Patent for Abuse Deterrent Drug Formulations

PALATINE, IL--(Marketwired - Apr 4, 2013) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs, today announced that the company has...
March 15, 2013 12:01 ET | Source: Acura Pharmaceuticals, Inc.

Acura Pharmaceuticals' Universal Shelf Registration Statement Declared Effective

PALATINE, IL--(Marketwire - Mar 15, 2013) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR) today announced that its universal shelf registration statement on Form S-3 was declared effective by the...
March 05, 2013 06:00 ET | Source: Acura Pharmaceuticals, Inc.

Acura Pharmaceuticals Reaches Key Milestone With Entrance Into Chain Drug Store Market

PALATINE, IL--(Marketwire - Mar 5, 2013) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR) today announced that its new next generation pseudoephedrine with abuse deterrent technology will now be...
March 04, 2013 16:15 ET | Source: Acura Pharmaceuticals, Inc.

Acura Pharmaceuticals Announces Fourth Quarter and Full Year 2012 Financial Results

PALATINE, IL--(Marketwire - Mar 4, 2013) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company developing products intended to address medication abuse and misuse,...
February 22, 2013 10:00 ET | Source: Acura Pharmaceuticals, Inc.

Acura Pharmaceuticals to Present at the Cowen Health Care Conference on March 5, 2013

PALATINE, IL--(Marketwire - Feb 22, 2013) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company developing products intended to address medication abuse and misuse,...
December 20, 2012 08:00 ET | Source: Acura Pharmaceuticals, Inc.

Acura Pharmaceuticals, Inc. Submits Investigational New Drug Application

PALATINE, IL--(Marketwire - Dec 20, 2012) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR) today announced that an Investigational New Drug application ("IND") has been filed with the U.S. Food and...
December 10, 2012 08:00 ET | Source: Acura Pharmaceuticals, Inc.

Acura Pharmaceuticals Launches Next Generation Cold Medicine to Aid in the Fight Against Meth

PALATINE, IL--(Marketwire - Dec 10, 2012) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR) today announced the launch of Nexafed® [pseudoephedrine hydrochloride (HCl)], a 30 mg immediate-release...
November 20, 2012 16:15 ET | Source: Acura Pharmaceuticals, Inc.

Acura Pharmaceuticals Announces Successful Bioequivalent Study for NEXAFED

PALATINE, IL--(Marketwire - Nov 20, 2012) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company developing products intended to address medication abuse and misuse,...